SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
OSI Pharmaceuticals (OSIP) - formerly Oncogene
An SI Board Since December 1997
Posts SubjectMarks Bans Symbol
447 40 0 OSIP
Emcee:  James Reynolds Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
397investorshub.comDewDiligence_on_SI-6/1/2006
396Interim PII data for Macugen versus central retinal vein occlusion: >>Pretuck-6/1/2006
395Dr. Goddard: Refreshing your memory, with excerpts from your S.E.C. disclosuresscaram(o)uche-5/31/2006
394Dr. Goddard: What do you suppose people think, when they read the questions thascaram(o)uche-5/31/2006
393Colin Goddard: There's an outstanding question, one that absolutely fascinascaram(o)uche-5/31/2006
392>>Genentech Announces June 2 Webcast Discussion of Lucentis Data Presentedtuck-5/20/2006
391>>Mixed Results for OSI By Althea Chang TheStreet.com Staff Reporter 5/9tuck-5/9/2006
390Goldman Sachs report on ARVO conference: investorshub.comDewDiligence_on_SI-5/5/2006
389>>MELVILLE, N.Y.--(BUSINESS WIRE)--April 17, 2006--OSI Pharmaceuticals, Intuck-4/17/2006
388<<When you do this over and over, it can add up to real money :-)>> Miljenko Zuanic-4/12/2006
387<i>Looks as though you could have stuck to your short a little longer.<DewDiligence_on_SI-4/12/2006
386From DNA's quarterly PR: >>U.S. sales of Tarceva® (erlotinib) intuck-4/12/2006
385<b> Macugen Label Amended to Include Allergic Reaction </b> yahoo.rDewDiligence_on_SI-4/7/2006
384Interesting post, Dew. A non-disclosed target by Flossie Wong-Stahl (of HIV famBiotech Jim-4/3/2006
383Two AMD items: tinyurl.com (New collaboration) tinyurl.com (Avastin)DewDiligence_on_SI-4/3/2006
382From OSIP 10K report (page 2): >> The Eyetech acquisition has been viewedDewDiligence_on_SI-3/24/2006
381Re: Macugen vs Lucentis head-to-head trial <i>It can not be blinded, it wDewDiligence_on_SI-3/13/2006
380Colin Goddard: There's an outstanding question, one that absolutely fascinascaram(o)uche-3/13/2006
379Details, details. :-)scaram(o)uche-3/13/2006
378It can not be blinded, it will be hard to randomize, so why doit?Miljenko Zuanic-3/10/2006
377From OSIP R&D Day webcast: >><i> Q: “Would you be willing to doDewDiligence_on_SI-3/10/2006
376I think Goddard’s “Lucentis is unsafe” mantra is turning stale and has about pladavid nordic-3/8/2006
375<i>Its too early to call.</i> The guidance cut already happened. MoDewDiligence_on_SI-3/8/2006
3742. Reason for the $100 cut in revenue guidance: OSIP underestimated the threat fdavid nordic-3/8/2006
373OSIP reduces 2006 guidance: investorshub.comDewDiligence_on_SI-3/8/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News